MicroRNA ‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)
ConclusionsIntegrating biomarkers across different body fluids would synergistically improve the early detection of NSCLC.Key points
Lung cancer is a heterogeneous disease and develops from complex aberrations.
Integrating sputum and plasma miRNAs has higher accuracy than when they are used alone
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Jipei Liao,
Jun Shen,
Qixin Leng,
Meng Qin,
Min Zhan,
Feng Jiang Tags: ORIGINAL ARTICLE Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Lung Cancer | Men | Non-Small Cell Lung Cancer | Skin Cancer | Smokers | Squamous Cell Carcinoma | Training | Universities & Medical Training